• Thymosin-β4 Promotes Angiogenesis in CLI via Notch/NF-κB Reg

  2026-07-08

  Lv et al. provide evidence that thymosin-β4 (Tβ4) enhances angiogenesis in critical limb ischemia (CLI) by modulating Notch and NF-κB signaling. The study's use of genetic and pharmacological tools, including the IKK-1/IKK-2 inhibitor BMS-345541, clarifies the mechanistic basis for Tβ4-driven vascular growth in ischemic tissue.

• ALDH2 Activation Delays Heart Failure by Promoting Cardiomyo

  2026-07-07

  The reference study demonstrates that pharmacological activation of ALDH2 extends the proliferative capacity of cardiomyocytes in mice, effectively delaying the onset of heart failure induced by ventricular pressure overload. These findings highlight ALDH2 as a promising molecular target for cardiac regeneration strategies and provide mechanistic insights with direct implications for cardiac ischemia research.

• Psora 4: Precision Kv1.3 Blocker for Immune Cell Research

  2026-07-07

  Psora 4 stands out as a potent and selective Kv1.3 blocker, enabling targeted inhibition of effector memory T cells without broadly impacting immune function. This guide details how to optimize experimental workflows, enhance assay reproducibility, and address troubleshooting in T cell and nephrology models using Psora 4 from APExBIO.

• ABT-199 (Venetoclax): Precision Bcl-2 Targeting in Hematolog

  2026-07-06

  This thought-leadership article examines the evolving scientific and translational landscape for ABT-199 (Venetoclax), a benchmark Bcl-2 inhibitor for hematologic malignancy research. We synthesize mechanistic insights, highlight experimental validation, and analyze emerging strategies—such as combinatorial targeting—to overcome resistance in non-Hodgkin lymphoma and AML models. Drawing on recent literature and advanced research guides, we provide actionable guidance and protocol parameters for translational researchers. This article uniquely bridges mechanistic discovery with strategic deployment, differentiating itself from standard product pages.

• Arachidonic Acid in Neurovascular Modeling: Beyond Inflammat

  2026-07-06

  Explore how Arachidonic Acid, a polyunsaturated omega-6 fatty acid, advances neurovascular and translational stroke research far beyond inflammation studies. This article uncovers its pivotal role in modeling blood-brain barrier dynamics, cellular signaling, and neuroinflammatory pathway interrogation.

• Practical Use of Omeprazole (A2845) for H+,K+-ATPase Inhibit

  2026-07-05

  Omeprazole (SKU A2845) is a highly pure H+,K+-ATPase inhibitor optimized for research into gastric acid secretion and antiulcer mechanisms. It is strictly intended for in vitro and ex vivo laboratory protocols and is not suitable for diagnostic or therapeutic use. This article addresses practical handling, protocol design, and troubleshooting for reliable data generation.

• PPT (Propyl Pyrazole Triol): Selective ERα Agonist for Resea

  2026-07-04

  PPT (Propyl Pyrazole Triol) is a highly selective estrogen receptor alpha (ERα) agonist with over 400-fold selectivity versus ERβ. This compound enables precise dissection of ERα-mediated gene regulation in oncology and developmental biology. Its robust selectivity and reproducible activity support mechanistic research and biomarker discovery.

• BIRC2 and BIRC3 Regulation by Cytokines and Glucocorticoids

  2026-07-03

  This study elucidates the differential regulation of BIRC2 and BIRC3 in pulmonary epithelial cells exposed to inflammatory cytokines and glucocorticoids. The findings clarify distinct expression patterns and regulatory mechanisms, refining our understanding of apoptosis and NF-κB signaling in airway biology.

• Cholesterol: Principal Sterol for Membrane and LNP Research

  2026-07-03

  Cholesterol is the principal sterol in higher animals, essential for membrane structure and function. It is widely used in lipid metabolism research and as a component of lipid nanoparticles for mRNA delivery. This article provides evidence-backed guidance on its roles, mechanisms, and research applications.

• Strategic TET Inhibition: Advancing Epigenetic Control in Os

  2026-07-02

  This article delivers a thought-leadership perspective on leveraging structure-based TET enzyme inhibition—exemplified by Bobcat339—to unravel and strategically modulate DNA methylation dynamics in osteogenic differentiation and age-related bone loss. By synthesizing mechanistic breakthroughs in senile osteoporosis with actionable guidance for translational researchers, we outline a roadmap for integrating Bobcat339 into precision epigenetics studies and highlight its potential in therapeutic exploration beyond conventional reagent paradigms.

• Glucocorticoid Modulation of CaV1.2 and Kv2.1 in Hippocampal

  2026-07-02

  This study reveals a rapid, nongenomic mechanism by which glucocorticoids suppress CaV1.2-mediated calcium signals in hippocampal neurons via endocytosis of Kv2.1 channel clusters. The findings clarify the molecular interplay between glucocorticoids, Kv2.1, and CaV1.2 channels, with implications for stress signaling and neuronal function in the hippocampus.

• Rocilinostat (ACY-1215): Redefining HDAC6 Inhibition in Tran

  2026-07-01

  Explore how Rocilinostat (ACY-1215) transforms selective HDAC6 inhibition into a strategic asset for translational oncology. This thought-leadership article bridges mechanistic insight, experimental best practices, and future outlook—empowering researchers to harness targeted epigenetic modulation in multiple myeloma and beyond.

• Obacunone Induces Ferroptosis in Ovarian Cancer via Akt/p53

  2026-07-01

  This study demonstrates that Obacunone, a citrus-derived compound, promotes ferroptosis and suppresses ovarian cancer cell proliferation by modulating the Akt/p53 signaling axis. The findings highlight the therapeutic potential of targeting ferroptosis pathways in ovarian cancer and provide mechanistic insight into Obacunone’s anticancer effects.

• Cy3 Goat Anti-Rabbit IgG (H+L) Antibody: Practical Workflow

  2026-06-30

  The Cy3 Goat Anti-Rabbit IgG (H+L) Antibody provides sensitive, specific detection of rabbit primary antibodies in fluorescence-based assays. Researchers should use this reagent for immunofluorescence, immunohistochemistry, or flow cytometry, but avoid clinical or diagnostic applications. Proper storage, handling, and protocol optimization are crucial for reliable results.

• Biochemical Characterization of GOB-38 β-Lactamase in E. ano

  2026-06-30

  This study delineates the substrate specificity and structural features of the novel GOB-38 metallo-β-lactamase from Elizabethkingia anophelis, elucidating its role in broad-spectrum β-lactam antibiotic resistance and its potential for interspecies resistance transfer. The findings have implications for resistance surveillance and the rational design of β-lactamase assays and inhibitor screens.

451 records 12/31 page Previous Next First page 上5页 1112131415 下5页 Last page